vx has been researched along with Weight Gain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassel, G; Elfsmark, D; Göransson Nyberg, A; Heldestad, V; Rocksén, D; Wallgren, K | 1 |
| Hall, T; Passingham, S; Wetherell, J | 1 |
2 other study(ies) available for vx and Weight Gain
| Article | Year |
|---|---|
An animal model to study health effects during continuous low-dose exposure to the nerve agent VX.
Topics: Acetylcholinesterase; Animals; Blood Pressure; Chemical Warfare Agents; Cholinesterase Inhibitors; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Male; Organothiophosphorus Compounds; Osmosis; Rats; Rats, Wistar; Respiration; Telemetry; Thyroid Gland; Thyroxine; Weight Gain | 2008 |
Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig.
Topics: Animals; Antidotes; Body Temperature; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterases; Drug Implants; Guinea Pigs; Male; Muscarinic Antagonists; Organothiophosphorus Compounds; Physostigmine; Pyridostigmine Bromide; Scopolamine; Weight Gain | 2002 |